Earnings Labs
InflaRx N.V. logo

InflaRx N.V. (IFRX) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$1.65

+2.48%

Mkt Cap $64.44M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 19, 2026

$27.31K-$17.62K-164.52%-$0.18-$0.17+5.56%
Q4 2025

Nov 10, 2025

$26.17K$27.91K+6.65%-$0.16-$0.16+0.00%
Q3 2025

Aug 7, 2025

$26.00K$46.43K+78.57%-$0.24-$0.24+0.00%
Q2 2025

May 7, 2025

$19.38K-$0.18-$0.14+22.22%
Q1 2025

Mar 20, 2025

$47.00K-$438-100.93%-$0.27-$0.09+66.67%
Q4 2024

Nov 8, 2024

$133.33K$135.80K+1.85%-$0.27-$0.33-22.22%
Q3 2024

Aug 8, 2024

$90.00K$6.83K-92.41%-$0.21-$0.26-23.81%
Q2 2024

May 8, 2024

$1.36M$38.71K-97.15%-$0.24-$0.19+20.83%
Q1 2024

Mar 21, 2024

$1.40M$2.51K-99.82%-$0.20-$0.30-50.00%
Q4 2023

Nov 1, 2023

$2.15M$64.14K-97.02%-$0.29-$0.14+51.72%
Q3 2023

Aug 10, 2023

-$0.36-$0.15+58.33%
Q2 2023

May 11, 2023

$239.25K-$0.30-$0.27+10.00%
Q1 2023

Mar 22, 2023

$0.25-$0.18-172.00%
Q4 2022

Nov 9, 2022

-$0.36-$0.18+50.00%
Q3 2022

Aug 5, 2022

-$0.34$0.01+102.94%
Q2 2022

May 12, 2022

-$0.34-$0.36-5.88%
Q1 2022

Mar 24, 2022

$5.87M-$0.37-$0.33+10.81%
Q4 2021

Nov 5, 2021

$5.91M-$0.37-$0.32+13.51%
Q3 2021

Aug 5, 2021

-$0.25-$0.40-60.00%
Q2 2021

May 12, 2021

-$0.26-$0.22+15.38%
Q1 2021

Mar 25, 2021

-$0.29-$0.38-31.03%
Q4 2020

Oct 29, 2020

-$0.41-$0.29+29.27%
Q3 2020

Jul 30, 2020

-$0.40-$0.42-5.00%
Q2 2020

May 21, 2020

-$0.59-$0.35+40.68%
Q2 2020

Apr 29, 2020

-$0.58
Q4 2019

Nov 7, 2019

-$0.58-$0.62-6.90%
Q3 2019

Aug 14, 2019

-$0.55-$0.66-20.00%
Q2 2019

May 23, 2019

-$0.62-$0.43+30.65%
Q1 2019

Mar 28, 2019

-$0.44-$0.46-4.55%
Q4 2018

Nov 21, 2018

-$0.41-$0.31+24.39%
Q3 2018

Aug 9, 2018

-$0.40-$0.12+70.00%
Q2 2018

May 17, 2018

-$0.28-$0.40-42.86%
Q1 2018

Mar 29, 2018

$271.03K-$0.25-$2.16-764.00%
Q4 2017

Dec 21, 2017

-$0.20-$0.14+30.00%
Q4 2017

Nov 8, 2017

-$0.23
Q1 2017

Mar 31, 2017

-$0.17
Q4 2016

Dec 31, 2016

-$0.20
Q3 2016

Sep 30, 2016

-$0.10
Q2 2016

Jun 30, 2016

-$0.05
Q1 2016

Mar 31, 2016

-$5.87